Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 188

Results For "NITI"

3574 News Found

Aurobindo Pharma receives USFDA approval for Mometasone Furoate Monohydrate nasal spray
Drug Approval | March 20, 2024

Aurobindo Pharma receives USFDA approval for Mometasone Furoate Monohydrate nasal spray

The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024


Aster’s India and GCC business separation nearing completion
Healthcare | March 20, 2024

Aster’s India and GCC business separation nearing completion

The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value


AstraZeneca to acquire Amolyt Pharma
News | March 18, 2024

AstraZeneca to acquire Amolyt Pharma

Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition


Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr
News | March 17, 2024

Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr

Both organisations enter into a long- term collaboration to expand patient access in India


Cipla appoints Venkata Sai Mungara as Global Head – Supply Chain
People | March 17, 2024

Cipla appoints Venkata Sai Mungara as Global Head – Supply Chain

Mungara has over 25+ years of experience in the supply chain domain


Bayer and Aignostics to collaborate on next generation precision oncology
News | March 16, 2024

Bayer and Aignostics to collaborate on next generation precision oncology

Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development


Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Clinical Trials | March 14, 2024

Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9

Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers


Nirma acquires majority stake in Glenmark Life Sciences
News | March 13, 2024

Nirma acquires majority stake in Glenmark Life Sciences

Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals


Jubilant Ingrevia partners with O2 Renewable to increase use of green energy
News | March 13, 2024

Jubilant Ingrevia partners with O2 Renewable to increase use of green energy

This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources